recent articles

From MIT News: Predictions from the OncoNPC model could enable doctors to choose targeted treatments for difficult-to-treat tumors. For a small percentage of cancer patients, doctors are unable to determine where their cancer originated....

PathAI co-founder Khosla carves a new path as CTO of Iterative Scopes At a fork in the road, Aditya Khosla, Ph.D., is taking the path less traveled: one that will take him away from PathAI, the company he helped start half a decade...

Jan 3, 2022 | MIT’s deep learning artificial intelligence algorithm demonstrates how similar new technologies and smartphones can be combined to give dermatologists and dermatopathologists valuable new ways to diagnose skin cancer from...

January 28, 2021 - Researchers created a risk-assessment algorithm that shows consistent performance across datasets from US, Europe, and Asia. To catch cancer earlier, we need to predict who is going to get it in the future. The complex...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and PathAI, a company that develops artificial intelligence technology for pathology, are collaborating with the aim to develop solutions that improve the precision...

OR

platinum partners

gold partners

Silver Partners

Media Partners